Sumitomo Mitsui Trust Group’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,930
Closed -$235K 1063
2024
Q4
$235K Buy
1,930
+230
+14% +$28K ﹤0.01% 1017
2024
Q3
$212K Buy
1,700
+300
+21% +$37.5K ﹤0.01% 1038
2024
Q2
$221K Sell
1,400
-2,981
-68% -$471K ﹤0.01% 1044
2024
Q1
$567K Sell
4,381
-2,271
-34% -$294K ﹤0.01% 1010
2023
Q4
$641K Sell
6,652
-1,340
-17% -$129K ﹤0.01% 1021
2023
Q3
$969K Buy
7,992
+2,172
+37% +$263K ﹤0.01% 989
2023
Q2
$667K Sell
5,820
-702
-11% -$80.4K ﹤0.01% 1034
2023
Q1
$899K Sell
6,522
-2,783
-30% -$384K ﹤0.01% 1012
2022
Q4
$1.21M Sell
9,305
-81
-0.9% -$10.5K ﹤0.01% 1002
2022
Q3
$1.04M Sell
9,386
-2,096
-18% -$232K ﹤0.01% 1028
2022
Q2
$861K Sell
11,482
-196
-2% -$14.7K ﹤0.01% 1062
2022
Q1
$912K Sell
11,678
-548
-4% -$42.8K ﹤0.01% 1055
2021
Q4
$1.1M Sell
12,226
-476
-4% -$42.9K ﹤0.01% 1018
2021
Q3
$1.18M Sell
12,702
-19,314
-60% -$1.79M ﹤0.01% 1011
2021
Q2
$2.49M Sell
32,016
-415,139
-93% -$32.3M ﹤0.01% 926
2021
Q1
$33.3M Buy
447,155
+114,642
+34% +$8.54M 0.02% 635
2020
Q4
$56.7M Sell
332,513
-3,126
-0.9% -$533K 0.04% 487
2020
Q3
$47.1M Sell
335,639
-47,952
-13% -$6.73M 0.03% 502
2020
Q2
$61.5M Sell
383,591
-26,893
-7% -$4.31M 0.04% 432
2020
Q1
$40.2M Buy
410,484
+6,246
+2% +$611K 0.03% 497
2019
Q4
$52.2M Sell
404,238
-1,094
-0.3% -$141K 0.04% 467
2019
Q3
$30.5M Buy
405,332
+317,840
+363% +$23.9M 0.03% 575
2019
Q2
$13.3M Buy
87,492
+45,024
+106% +$6.84M 0.01% 704
2019
Q1
$5.06M Buy
+42,468
New +$5.06M ﹤0.01% 723